2026-525208-90-00CompletedPhase 1
A Phase 1, drug-drug interaction trial of IMU-838 with oral contraceptives in women
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Jun 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 3 Feb 2026
- Start date
- 1 Apr 2026
- Lead sponsor
- Immunic AG
- Diseases
- Multiple sclerosis
- EU CT number
- 2026-525208-90-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 26
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| SGS Belgium | Edegem | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.